| Moderna Switzerland GmbH - Spikevax XBB.1.5 0.10 mg/ml, Dispersion zur Injektion | | 69465 | | 01 | | Spikevax XBB.1.5 0.10 mg/ml | | Dispersion zur Injektion | | J07BN01 | | | | 26.09.2023 | | |
| | Composition | | Suspension: andusomeranum 0.050 mg pro dosi, heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas, cholesterolum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, 1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus, trometamolum, trometamoli hydrochloridum, acidum aceticum, natrii acetas trihydricus, saccharum, aqua ad iniectabile, pro dosi, natrium 0.017 mg. | | Packungsbestandteile | | Dispersion zur Injektion | | | | Principe actif | Concentr. | informations additionels |
|---|
| Andusomeranum | 0.05 mg | Suspension |
| | | | Agents auxilliaires | Concentr. |
|---|
| 1,2-dimyristoyl-Rac-Glycero-3-Polyethylenglycoli | 2000 | | 1,2-distearoyl-Sn-Glycero-3-Phosphocholinum | | | Acide Acétique | | | Aether Methylicus | | | Cholesterol | | | Sodium Acetate Trihydrate | | | Sodium | 0.017 mg | | Saccharumaqua | | | Trometamoli Hydrochloridum | | | Trometamol | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 10 | DDP | DDP | B | | Non | | 002 | 10 | DDP | DDP | B | | Non |
|
|
